COMP <GO>
VRT vs LRCX // EV/EBITDA & P/E VALUATION
Vertiv Holdings LLC (NYSE) VS. Lam Research Corporation (NASDAQ) • 15-METRIC TALLY: VRT 4
— LRCX 10
▲ EV/EBITDA & P/E VALUATION LEADER: LRCX
LAST: $232.50 (-5.46%) • MKT CAP: $94.69B
valuation
47.5x
LAST: $239.11 (-6.01%) • MKT CAP: $317.78B
valuation
34.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VRT VS. LRCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VRT | LRCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.30% | 50.50% | -14.20 | LRCX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.10% | 25.50% | -6.40 | LRCX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 47.5x | 34.8x | +12.70 | LRCX | /valuation <GO> |
| Free Cash Flow Yield | 2.00% | 1.51% | +0.49 | VRT | /fcf-yield <GO> |
| Operating Margin | 17.90% | 35.30% | -17.40 | LRCX | /operating-margins <GO> |
| Net Profit Margin | 13.00% | 31.30% | -18.30 | LRCX | /net-margins <GO> |
| Revenue Growth (YoY) | 27.70% | 26.00% | +1.70 | VRT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.07% | 0.40% | -0.33 | LRCX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.56 | 21.80 | -13.24 | LRCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | VRT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 41.7 | +15.10 | VRT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.24 | 1.29 | -0.05 | LRCX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 59.6x | 36.7x | +22.90 | LRCX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $94.69B | $317.78B | -$223.08B | LRCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VRT REV | LRCX REV | VRT GROSS % | LRCX GROSS % | VRT FCF | LRCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $10.23B | $23.23B | 36.3% | 50.5% | $1.89B | $4.81B |
| FY 2024 | $8.01B | $18.44B | 36.6% | 48.7% | $1.15B | $5.34B |
| FY 2023 | $6.86B | — | — | — | $591.7M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VRT // BETA 1.24
LRCX // BETA 1.29